Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Wai Chun Bio-Technology Ltd. ( (HK:0660) ) is now available.
Wai Chun Bio-Technology Limited has announced a substantial reduction in its net loss for the year ended 30 June 2025, with losses expected to not exceed HK$13.0 million, compared to approximately HK$65.7 million the previous year. This improvement is primarily due to a decrease in impairment losses on non-financial assets, indicating a positive shift in the company’s financial health.
More about Wai Chun Bio-Technology Ltd.
Wai Chun Bio-Technology Limited is a company incorporated in the Cayman Islands, operating in the bio-technology industry. The company focuses on the development and production of bio-technological products and services.
Average Trading Volume: 405,150
Technical Sentiment Signal: Buy
Current Market Cap: HK$29.81M
Learn more about 0660 stock on TipRanks’ Stock Analysis page.